Volume Alert - SHLD 42.81 Sears Holdings Corp $SHLD Hit a

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - SHLD 42.81 Sears Holdings Corp $SHLD Hit a high today of 48.25 Closing the day 11/07/14 at 42.81 +10.14 +31.04% With a day low of 39.51 and a total volume of 11,945,335.

SHLD Recent Posts: http://investorshangout.com/Sears-Holdings-Corp-SHLD-55418/

SHLD Sears Holdings Corp Recent Headline News

Sears eyes REIT to raise cash
at Investor's Business Daily - Fri Nov 07, 5:36PM CST
Shares of the operator of Sears and K-Mart department stores surged early Fri. after the company said it contemplates forming a real estate investment trust (REIT) and selling 200-300 of its own stores to the REIT to raise cash. In an SEC filing, a...
SHLD: 42.81 (+10.14)

Nasdaq stocks posting largest percentage increases
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
SWIR: 33.90 (+0.30), PERI: 5.75 (-0.35), UNXL: 5.31 (+0.77), TREE: 47.03 (+3.12), SSRI: 5.20 (+0.88), STMP: 42.92 (+0.93), RPRX: 10.12 (+3.67), NYNY: 7.74 (-0.22), SHLD: 42.81 (+10.14), AREX: 10.73 (+1.88), PGNX: 5.37 (+0.76), ECYT: 6.03 (-0.46), SSO.TO: 5.90 (+0.95), SGMA: 7.21 (-0.64), SW.TO: 38.39 (-0.04), PLNR: 6.40 (+0.01)

Final Glance: Department Store Retail companies
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — Shares of some top department store retail companies were mixed at the close of trading:
KSS: 57.22 (+0.41), TJX: 64.00 (-0.56), JWN: 73.43 (-0.25), M: 59.88 (+0.84), SHLD: 42.81 (+10.14)

FTI Consulting's Study Expects 3.5% Jump in Holiday Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 07, 4:55PM CST
Recent research by FTI Consulting (FCN) projected nominal holiday sales to register a 3.5% increase this season, indicating a healthy pickup from the disappointing holiday performance of 2013.
KSS: 57.22 (+0.41), M: 59.88 (+0.84), SHLD: 42.81 (+10.14), FCN: 40.73 (-0.34)


Sears explores sale-leaseback deal of buildings
AP - Fri Nov 07, 3:56PM CST
NEW YORK (AP) — Sears Holdings' stock soared Friday after the struggling retailer said it's considering selling about 200 to 300 of its buildings to boost its liquidity.
WMT: 78.77 (+0.96), SHLD: 42.81 (+10.14)

Watch for Sears Holdings to Potentially Pullback After Gaining 31.04% Yesterday
Comtex SmarTrend(R) - Fri Nov 07, 3:42PM CST
Sears Holdings (NASDAQ:SHLD) traded in a range yesterday that spanned from a low of $39.51 to a high of $48.25. Yesterday, the shares gained 31.0%, which took the trading range above the 3-day high of $36.50 on volume of 11.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SHLD: 42.81 (+10.14)

Sears Holdings Rises 31.04% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Nov 07, 3:41PM CST
Sears Holdings (NASDAQ:SHLD) traded in a range yesterday that spanned from a low of $39.51 to a high of $48.25. Yesterday, the shares gained 31.0%, which took the trading range above the 3-day high of $36.50 on volume of 11.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SHLD: 42.81 (+10.14)

Market News: Sears, Salix Pharmaceuticals, Walt Disney
at The Street - Fri Nov 07, 3:38PM CST
The Department of Labor reported that American companies added 214,000 jobs and the unemployment rate declined to 5.8%The stock markets in the United States fluctuated and eventually ended the trading...
SLXP: 91.47 (-47.08), DIS: 90.00 (-2.00), SHLD: 42.81 (+10.14)

Humana and Salix are big market movers
AP - Fri Nov 07, 3:34PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
WFM: 46.81 (+1.96), TSLA: 240.20 (-1.02), FSLR: 50.29 (-6.12), RIG: 29.71 (-0.21), WWWW: 15.40 (+0.68), GNRC: 40.86 (-1.23), SLXP: 91.47 (-47.08), BRKR: 17.91 (-2.98), KATE: 30.37 (-0.59), GNW: 8.41 (-0.25), SHLD: 42.81 (+10.14), ANR: 2.91 (+0.39), MCO: 98.95 (-0.04), HUM: 130.58 (-9.29)


Dow, S&P 500 eke out gains, set record highs
By MATTHEW CRAFT - AP - Fri Nov 07, 4:08PM CST
NEW YORK (AP) — An encouraging report on hiring barely fazed the stock market Friday, leaving indexes with the slightest of gains. For investors, good is no longer good enough.
TM: 118.67 (-1.16), SHLD: 42.81 (+10.14), HUM: 130.58 (-9.29)

Stock Market Today: Dow Scores Third Straight Record Close on Jobs Data
at The Street - Fri Nov 07, 3:22PM CST
The Dow Jones Industrial Average posts a small gain in the final minutes to closing bell, just enough to cement the index's third consecutive record close.
MNST: 108.39 (+7.91), FSLR: 50.29 (-6.12), SLXP: 91.47 (-47.08), AKS: 6.62 (+0.48), SHLD: 42.81 (+10.14), VSAT: 65.39 (+5.13)

Sears Soars Nearly +40% As REIT News Boosts Confidence
at The Street - Fri Nov 07, 2:42PM CST
Repros Therapeutics Inc (NASDAQ:RPRX), Sears Holdings Corp (NASDAQ:SHLD) and Allied Nevada Gold Corp. (NYSEMKT:ANV) are among the top-gaining billionaire stock picks of the day. On the losing end ar...
ANV: 1.05 (+0.19), AMSC: 1.17 (-0.19), RPRX: 10.12 (+3.67), SHLD: 42.81 (+10.14), STAY: 18.30 (-5.00)

Stock Market Today: Dow, S&P 500 Give Up Small Gains in Final Hour
at The Street - Fri Nov 07, 2:19PM CST
U.S. stocks slip on Friday afternoon, though with only slight moves, as Wall Street overlooks a mixed October jobs report to digest the big picture of a tightening labor market.
MNST: 108.39 (+7.91), FSLR: 50.29 (-6.12), SLXP: 91.47 (-47.08), DIS: 90.00 (-2.00), SHLD: 42.81 (+10.14)

Midday Glance: Department Store Retail companies
AP - Fri Nov 07, 12:18PM CST
NEW YORK (AP) — Shares of some top department store retail companies are mixed at 1 p.m.:
KSS: 57.22 (+0.41), TJX: 64.00 (-0.56), JWN: 73.43 (-0.25), M: 59.88 (+0.84), SHLD: 42.81 (+10.14)

Sears Tries a REIT in the Face of Falling Ebitda and a Cash Burn
at The Street - Fri Nov 07, 12:06PM CST
As a way to raise money, department store chain said it's investigating a REIT and sale-leaseback plan.
SHLD: 42.81 (+10.14)

Why Sears Holdings Corp. Stock Skyrocketed Today
Steve Symington, The Motley Fool - Motley Fool - Fri Nov 07, 10:42AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What:  Shares of Sears Holdings Corp. soared 34% early...
SHLD: 42.81 (+10.14)

Sears Mulls REIT To Bring In Cash, Sees Flat Comps
at Investor's Business Daily - Fri Nov 07, 10:02AM CST
Shares of Sears Holdings are surging in morning trading as the struggling department store chain contemplates forming a real estate investment trust (REIT) and selling 200-300 of its own stores to the REIT to raise cash. In an SEC filing, Sears...
M: 59.88 (+0.84), SHLD: 42.81 (+10.14)

Early Glance: Department Store Retail companies
AP - Fri Nov 07, 9:53AM CST
NEW YORK (AP) — Shares of some top department store retail companies are mixed at 10 a.m.:
KSS: 57.22 (+0.41), TJX: 64.00 (-0.56), JWN: 73.43 (-0.25), M: 59.88 (+0.84), SHLD: 42.81 (+10.14)

Sears' Desire to Become a REIT Masks Retailer's Major Challenges
at The Street - Fri Nov 07, 9:42AM CST
Sears is now trying to become a REIT, masking a disappointing preliminary third quarter set of results. Brian Sozzi reports.
AMZN: 299.86 (+3.22), TGT: 64.17 (+2.28), JCP: 7.82 (+0.34), WMT: 78.77 (+0.96), BBY: 35.18 (-0.03), SHLD: 42.81 (+10.14)

Sears Holdings Corp. (SHLDQ) Stock Research Links

SHLDQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 50

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 84

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Equitage Ventures Launches $47.3M Fund for Senior Care Tech

Updated Category News Views 329

Equitage Ventures Launches Significant Investment Fund Equitage Ventures, an early-stage venture capital firm dedicated to AgeTech, has announced the successful final closing of a substantial $47.3 million investment fund. This fund is designed to provide critical capital, distribution resources, and strategic guidance to innovative entrepreneurs who aim to tackle the...

Continue Reading
Understanding Market Trends: Insights into Chevron Corp's Performance

Updated Category News Views 171

Chevron Corp Market Sentiment Analysis Chevron Corp (NYSE: CVX) has experienced a noteworthy decline in its short interest as a percentage of float, showing a 10.26% decrease since its previous report. Currently, there are approximately 14.02 million shares sold short, which accounts for 0.7% of all shares available for trading. Given the trading volume, it is estimated...

Continue Reading
Establishment of Blakely McCrory Hope Fund at Moody Gardens

Updated Category News Views 200

Introducing the Blakely McCrory Hope Fund Moody Gardens is proud to announce a special initiative to honor the memory of a young girl who captured the hearts of many: the Blakely McCrory Hope Fund. This fund has been established in loving memory of 8-year-old Blakely McCrory, who lost her life in a tragic flooding incident that occurred during the summer months....

Continue Reading
Star-Studded Table Read of 'It's a Wonderful Life' Event

Updated Category News Views 221

Exciting Holiday Table Read for a Worthy Cause The Ed Asner Family Center is pulling out all the stops this holiday season with an exciting virtual table read of the beloved classic, "It's a Wonderful Life." Scheduled for December 14 at 5 PM PST, this event promises to spread joy while supporting individuals and families with special needs. Star-Studded Cast Comes...

Continue Reading
Transforming $100 Into Over $1700 with Monolithic Power Systems

Updated Category News Views 145

Understanding the Growth of Monolithic Power Systems Monolithic Power Systems (NASDAQ: MPWR) has showcased impressive financial performance over the past decade, outperforming many market benchmarks. With an impressive annualized growth rate of 19.88%, it has attracted the attention of savvy investors. The Power of Compounded Returns Imagine investing $100 in MPWR stock...

Continue Reading